Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ELBIT MEDICAL IMAGING - EMITF - U.S. OTC -- Ignore unavailable to you. Want to Upgrade?

To: peter michaelson who wrote (27)	4/1/1998 6:21:00 PM
From: leisuresports	Read Replies (1) \| Respond to of 79

Peter, I also think your valuation is too cheap. The way I look at it, Elbit Medicial bought Diasonics for around $70 million just a couple of years ago, turned the company around, and is now selling it for $230 million. I think that that indicates that management is at least somewhat competent, and I am willing to bet that they will be able to do something worthwhile with the big cash infusion that they are about to get. Also, Elscint is selling at its low these days and as we have noted in this discussion, at least one institution (Fidelity) has taken a position in Elscint. For these reasons I am definitely holding for awhile longer, as long as things go as expected.